33 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
disruptions, rising interest rates and volatility in the capital markets, and our long-term strategy as a company is dependent on our ability … financing to support the long-term clinical development of our programs, we intend to consider additional financing opportunities when market terms
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
to promote the creation of shareholder value over the long term, the board of directors recognizes that executive compensation disclosures are made … the long-term interests of our shareholders.
Shareholder Recommendations and Nominations
Our nominating and corporate governance committee considers
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
) the likely consequences of any decision in the long-term, (ii) the interests of the company’s employees, (iii) the need to foster the company’s business
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
program is designed to promote the creation of shareholder value over the long term, the board of directors recognizes that executive compensation … and is committed to represent the long-term interests of our shareholders.
Shareholder Recommendations and Nominations
Our nominating and corporate governance
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
) the likely consequences of any decision in the long-term, (ii) the interests of the company’s employees, (iii) the need to foster the company’s business … companies, and certain other financial institutions;
U.S. expatriates and certain former citizens or long-term residents of the United States
10-K
fdup3ebtm8wq1v
28 Feb 24
Annual report
7:33am
6-K
EX-99.2
ndz 4chg7fe
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.3
qv7zsg
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.4
5lpeg
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
ncqk5kj7hyynoj1 lbf
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
pctes0256hk
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.1
dib6fqzwlzt9oivbyic
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.2
d436pru2rgok37lmulqw
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
bui g88a9x3p3egl
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.3
r9r3tjw qy
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
8uk2b85
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-1.1
bkp890mhtup337
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
py9j4
9 Sep 22
Prospectus supplement for primary offering
4:23pm
424B7
uothi8r5 6fuc
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
vzvnwo4jrxrsyzab3
4 Apr 22
Automatic shelf registration (foreign)
4:08pm